Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 128

1.

A qPCR expression assay of IFI44L gene differentiates viral from bacterial infections in febrile children.

Gómez-Carballa A, Cebey-López M, Pardo-Seco J, Barral-Arca R, Rivero-Calle I, Pischedda S, Currás-Tuala MJ, Gómez-Rial J, Barros F, Martinón-Torres F, Salas A.

Sci Rep. 2019 Aug 13;9(1):11780. doi: 10.1038/s41598-019-48162-9.

2.

Meningococcal disease: Can we predict the unpredictable?

Martinón-Torres F, Trilla A.

Med Clin (Barc). 2019 Jul 23. pii: S0025-7753(19)30413-0. doi: 10.1016/j.medcli.2019.04.035. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
31350058
3.

Diversity in the emergency care for febrile children in Europe: a questionnaire study.

Borensztajn D, Yeung S, Hagedoorn NN, Balode A, von Both U, Carrol ED, Dewez JE, Eleftheriou I, Emonts M, van der Flier M, de Groot R, Herberg JA, Kohlmaier B, Lim E, Maconochie I, Martinón-Torres F, Nijman R, Pokorn M, Strle F, Tsolia M, Wendelin G, Zavadska D, Zenz W, Levin M, Moll HA.

BMJ Paediatr Open. 2019 Jun 27;3(1):e000456. doi: 10.1136/bmjpo-2019-000456. eCollection 2019.

4.

Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B (4CMenB) vaccine in infants: A post-hoc analysis in a phase 3b, randomised, controlled trial.

Safadi MAP, Martinon-Torres F, Weckx LY, Moreira ED Junior, da Fonseca Lima EJ, Willemsen A, Toneatto D, Habib MA, Borys D.

Vaccine. 2019 Aug 14;37(35):4858-4863. doi: 10.1016/j.vaccine.2019.07.021. Epub 2019 Jul 18.

5.

Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine.

Danier J, Rivera L, Claeys C, Dbaibo G, Jain VK, Kosalaraksa P, Woo W, Yanni E, Zaman K, Acosta B, Amanullah A, Ariza M, Luisa Arroba Basanta M, Bavdekar A, Carmona A, Cousin L, Diaz A, Diez-Domingo J, Cagri Dinleyici E, Faust SN, Garcia-Sicilia J, Gomez-Go GD, Antionette Gonzales L, Hacimustafaoglu M, Hughes SM, Izu A, Jackowska T, Kant S, Lucero M, Mares Bermudez J, Martinón-Torres F, Montellano M, Prymula R, Puthanakit T, Ruzkova R, Sadowska-Krawczenko I, Soni J, Szymanski H, Ulied A, Schuind A, Innis BL; Flu4VEC Study Group.

Pediatr Infect Dis J. 2019 Aug;38(8):866-872. doi: 10.1097/INF.0000000000002387.

PMID:
31306399
6.

False Vaccine Contraindications Among Healthcare Providers in Europe: A Short Survey Among Members of The European Society of Pediatric Infectious Diseases.

Rivero I, Raguindin PF, Buttler R, Martinon-Torres F.

Pediatr Infect Dis J. 2019 Sep;38(9):974-976. doi: 10.1097/INF.0000000000002401.

PMID:
31261366
7.

Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults.

Martinón-Torres F, Nolan T, Toneatto D, Banzhoff A.

Hum Vaccin Immunother. 2019 Jul 9:1-12. doi: 10.1080/21645515.2019.1627159. [Epub ahead of print]

PMID:
31246520
8.

The ReSVinet Score for Bronchiolitis: A Scale for All Seasons.

Justicia-Grande AJ, Martinón-Torres F.

Am J Perinatol. 2019 Jul;36(S 02):S48-S53. doi: 10.1055/s-0039-1691800. Epub 2019 Jun 25.

PMID:
31238359
9.

OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines.

Cotugno N, Ruggiero A, Santilli V, Manno EC, Rocca S, Zicari S, Amodio D, Colucci M, Rossi P, Levy O, Martinon-Torres F, Pollard AJ, Palma P.

J Immunol Res. 2019 Apr 28;2019:8732191. doi: 10.1155/2019/8732191. eCollection 2019. Review.

10.

Lifestyle and comorbid conditions as risk factors for community-acquired pneumonia in outpatient adults (NEUMO-ES-RISK project).

Rivero-Calle I, Cebey-López M, Pardo-Seco J, Yuste J, Redondo E, Vargas DA, Mascarós E, Díaz-Maroto JL, Linares-Rufo M, Jimeno I, Gil A, Molina J, Ocaña D, Martinón-Torres F.

BMJ Open Respir Res. 2019 Mar 12;6(1):e000359. doi: 10.1136/bmjresp-2018-000359. eCollection 2019.

11.

TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines.

Martinón-Torres F, Bosch X, Rappuoli R, Ladhani S, Redondo E, Vesikari T, García-Sastre A, Rivero-Calle I, Gómez-Rial J, Salas A, Martín C, Finn A, Butler R.

Hum Vaccin Immunother. 2019 Jun 3:1-11. doi: 10.1080/21645515.2019.1609823. [Epub ahead of print]

PMID:
31158041
12.

Further considerations on rotavirus vaccination and seizure-related hospitalization rates.

Gómez-Rial J, Sánchez-Batán S, Rivero-Calle I, Pardo-Seco J, Martinón-Martínez JM, Salas A, Martinón-Torres F.

Infect Drug Resist. 2019 Apr 29;12:989-991. doi: 10.2147/IDR.S208756. eCollection 2019. No abstract available.

13.

The challenge of the laboratory diagnosis in a confirmed congenital Zika virus syndrome in utero: A case report.

Sulleiro E, Frick MA, Rodó C, Espasa M, Thorne C, Espiau M, Martín-Nalda A, Suy A, Giaquinto C, Melendo S, Rando A, Alarcón A, Martinón-Torres F, Pumarola T, Soler-Palacín P, Soriano-Arandes A.

Medicine (Baltimore). 2019 May;98(20):e15532. doi: 10.1097/MD.0000000000015532.

14.

Identification of regulatory variants associated with genetic susceptibility to meningococcal disease.

Borghini L, Png E, Binder A, Wright VJ, Pinnock E, de Groot R, Hazelzet J, Emonts M, Van der Flier M, Schlapbach LJ, Anderson S, Secka F, Salas A, Fink C, Carrol ED, Pollard AJ, Coin LJ, Kuijpers TW, Martinon-Torres F, Zenz W, Levin M, Hibberd ML, Davila S; EUCLIDS consortium.

Sci Rep. 2019 May 6;9(1):6966. doi: 10.1038/s41598-019-43292-6.

15.

Ancestry patterns inferred from massive RNA-seq data.

Barral-Arca R, Pardo-Seco J, Bello X, Martinón-Torres F, Salas A.

RNA. 2019 Jul;25(7):857-868. doi: 10.1261/rna.070052.118. Epub 2019 Apr 22.

PMID:
31010885
16.

[What have we learnt about rotavirus in Spain in the last 10 years?]

Díez-Domingo J, Garcés-Sánchez M, Giménez-Sánchez F, Colomina-Rodríguez J, Martinón-Torres F.

An Pediatr (Barc). 2019 Apr 7. pii: S1695-4033(19)30076-1. doi: 10.1016/j.anpedi.2019.01.024. [Epub ahead of print] Spanish.

17.

Safety and immunogenicity of pneumococcal conjugate vaccines in preterm infants.

López-Sanguos C, Rivero Calle I, Rodriguez Tenreiro C, Raguindin PF, Martinón-Torres F.

Expert Opin Drug Saf. 2019 Apr;18(4):253-259. doi: 10.1080/14740338.2019.1597849. Epub 2019 Apr 4. Review.

PMID:
30907170
18.

Rotavirus infection beyond the gut.

Gómez-Rial J, Sánchez-Batán S, Rivero-Calle I, Pardo-Seco J, Martinón-Martínez JM, Salas A, Martinón-Torres F.

Infect Drug Resist. 2018 Dec 24;12:55-64. doi: 10.2147/IDR.S186404. eCollection 2019. Review.

19.

Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres.

Pepin S, Dupuy M, Borja-Tabora CFC, Montellano M, Bravo L, Santos J, de Castro JA, Rivera-Medina DM, Cutland C, Ariza M, Diez-Domingo J, Gonzalez CD, Martinón-Torres F, Papadopoulou-Alataki E, Theodoriadou M, Kazek-Duret MP, Gurunathan S, De Bruijn I; GQM05 Study Group.

Vaccine. 2019 Mar 22;37(13):1876-1884. doi: 10.1016/j.vaccine.2018.11.074. Epub 2018 Dec 14.

20.

Implementing Universal Varicella Vaccination in Europe: The Path Forward.

Spoulou V, Alain S, Gabutti G, Giaquinto C, Liese J, Martinon-Torres F, Vesikari T.

Pediatr Infect Dis J. 2019 Feb;38(2):181-188. doi: 10.1097/INF.0000000000002233.

PMID:
30408002

Supplemental Content

Loading ...
Support Center